401k Plan data: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN plan

ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 401k Plan overview

Plan Name	ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN
Plan identification number	001

ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.
Plan sponsor(s) received services of leased employees, as defined in Code section 414(n), during the plan year.

401k Sponsoring company profile

ANTARES PHARMA INC has sponsored the creation of one or more 401k plans.

Company Name: ANTARES PHARMA INC

Employer identification number (EIN): 411350192

NAIC Classification: 325410

Additional information about ANTARES PHARMA INC

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 3962625

More information about ANTARES PHARMA INC

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 HEATHER ROE
001 2016-01-01 L YOUNG
001 2015-01-01 LAURA A. YOUNG 2016-10-14 LAURA A. YOUNG 2016-10-14
001 2014-01-01 JAMES FICKENSCHER 2015-07-27
001 2013-01-01 ROBERT APPLE 2014-10-01
001 2012-01-01 ROBERT APPLE 2013-08-21 ROBERT APPL 2013-08-21
001 2011-01-01 ROBERT APPLE 2012-09-26 ROBERT APPLE 2012-09-26
001 2010-01-01 ROBERT APPLE 2011-08-18 ROBERT APPLE 2011-08-18

Plan id#	Filing Submission Date	Name of Administrator	Date Administrator Signed	Name of Company Sponsor	Date Sponsor Signed
001	2022-01-01
001	2021-01-01
001	2020-01-01
001	2019-01-01
001	2019-01-01
001	2018-01-01
001	2017-01-01	HEATHER ROE
001	2016-01-01	L YOUNG
001	2015-01-01	LAURA A. YOUNG	2016-10-14	LAURA A. YOUNG	2016-10-14
001	2014-01-01	JAMES FICKENSCHER	2015-07-27
001	2013-01-01	ROBERT APPLE	2014-10-01
001	2012-01-01	ROBERT APPLE	2013-08-21	ROBERT APPL	2013-08-21
001	2011-01-01	ROBERT APPLE	2012-09-26	ROBERT APPLE	2012-09-26
001	2010-01-01	ROBERT APPLE	2011-08-18	ROBERT APPLE	2011-08-18

Plan Statistics for ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN

401k plan membership statisitcs for ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN

Measure Date Value
2022: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 312
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 0
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 0
Total of all active and inactive participants 2022-01-01 0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 0
Total participants 2022-01-01 0
Number of participants with account balances 2022-01-01 0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 0
2021: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 272
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 189
Number of retired or separated participants receiving benefits 2021-01-01 15
Number of other retired or separated participants entitled to future benefits 2021-01-01 102
Total of all active and inactive participants 2021-01-01 306
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 0
Total participants 2021-01-01 306
Number of participants with account balances 2021-01-01 280
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 32
2020: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 250
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 183
Number of retired or separated participants receiving benefits 2020-01-01 15
Number of other retired or separated participants entitled to future benefits 2020-01-01 73
Total of all active and inactive participants 2020-01-01 271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 0
Total participants 2020-01-01 271
Number of participants with account balances 2020-01-01 231
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 16
2019: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 145
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 163
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 79
Total of all active and inactive participants 2019-01-01 242
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 0
Total participants 2019-01-01 242
Number of participants with account balances 2019-01-01 208
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 12
2018: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 145
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 107
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 38
Total of all active and inactive participants 2018-01-01 145
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 0
Total participants 2018-01-01 145
Number of participants with account balances 2018-01-01 134
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 16
2017: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 147
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 110
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 35
Total of all active and inactive participants 2017-01-01 145
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 145
Number of participants with account balances 2017-01-01 132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 20
2016: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 132
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 106
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 38
Total of all active and inactive participants 2016-01-01 144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 144
Number of participants with account balances 2016-01-01 128
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 23

Measure	Date	Value
2022: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	312
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	0
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	0
Total of all active and inactive participants	2022-01-01	0
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	0
Total participants	2022-01-01	0
Number of participants with account balances	2022-01-01	0
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	0
2021: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	272
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	189
Number of retired or separated participants receiving benefits	2021-01-01	15
Number of other retired or separated participants entitled to future benefits	2021-01-01	102
Total of all active and inactive participants	2021-01-01	306
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	0
Total participants	2021-01-01	306
Number of participants with account balances	2021-01-01	280
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	32
2020: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	250
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	183
Number of retired or separated participants receiving benefits	2020-01-01	15
Number of other retired or separated participants entitled to future benefits	2020-01-01	73
Total of all active and inactive participants	2020-01-01	271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	0
Total participants	2020-01-01	271
Number of participants with account balances	2020-01-01	231
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	16
2019: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	145
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	163
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	79
Total of all active and inactive participants	2019-01-01	242
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	0
Total participants	2019-01-01	242
Number of participants with account balances	2019-01-01	208
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	12
2018: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	145
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	107
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	38
Total of all active and inactive participants	2018-01-01	145
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	0
Total participants	2018-01-01	145
Number of participants with account balances	2018-01-01	134
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	16
2017: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	147
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	110
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	35
Total of all active and inactive participants	2017-01-01	145
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	145
Number of participants with account balances	2017-01-01	132
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	20
2016: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	132
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	106
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	38
Total of all active and inactive participants	2016-01-01	144
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	144
Number of participants with account balances	2016-01-01	128
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	23

Financial Data on ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN

Measure	Date	Value
2022 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-11-30	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-11-30	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-11-30	$0
Total income from all sources (including contributions)	2022-11-30	$-2,994,761
Total loss/gain on sale of assets	2022-11-30	$0
Total of all expenses incurred	2022-11-30	$24,685,473
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-11-30	$24,606,690
Value of total corrective distributions	2022-11-30	$30,160
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-11-30	$1,815,374
Value of total assets at end of year	2022-11-30	$0
Value of total assets at beginning of year	2022-11-30	$27,680,234
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-11-30	$48,623
Total interest from all sources	2022-11-30	$3,679
Total dividends received (eg from common stock, registered investment company shares)	2022-11-30	$146,079
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-11-30	Yes
Value of any plan assets that reverted to the employer resulting from resoluton to terminate the plan	2022-11-30	$0
Total dividends received from registered investment company shares (eg mutual funds)	2022-11-30	$146,079
Administrative expenses professional fees incurred	2022-11-30	$2,167
Was this plan covered by a fidelity bond	2022-11-30	Yes
Value of fidelity bond cover	2022-11-30	$1,000,000
If this is an individual account plan, was there a blackout period	2022-11-30	No
Were there any nonexempt tranactions with any party-in-interest	2022-11-30	No
Contributions received from participants	2022-11-30	$1,174,980
Participant contributions at end of year	2022-11-30	$0
Participant contributions at beginning of year	2022-11-30	$136,986
Income. Received or receivable in cash from other sources (including rollovers)	2022-11-30	$64,136
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-11-30	No
Value of net income/loss	2022-11-30	$-27,680,234
Value of net assets at end of year (total assets less liabilities)	2022-11-30	$0
Value of net assets at beginning of year (total assets less liabilities)	2022-11-30	$27,680,234
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-11-30	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-11-30	No
Were any leases to which the plan was party in default or uncollectible	2022-11-30	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-11-30	$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-11-30	$25,976,385
Interest on participant loans	2022-11-30	$3,679
Value of interest in common/collective trusts at end of year	2022-11-30	$0
Value of interest in common/collective trusts at beginning of year	2022-11-30	$1,566,863
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-11-30	$-4,959,893
Net investment gain or loss from common/collective trusts	2022-11-30	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-11-30	No
Was there a failure to transmit to the plan any participant contributions	2022-11-30	Yes
Has the plan failed to provide any benefit when due under the plan	2022-11-30	No
Contributions received in cash from employer	2022-11-30	$576,258
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-11-30	$24,606,690
Contract administrator fees	2022-11-30	$46,456
Did the plan have assets held for investment	2022-11-30	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-11-30	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-11-30	Yes
Opinion of an independent qualified public accountant for this plan	2022-11-30	Unqualified
Accountancy firm name	2022-11-30	BOULAY PLLP
Accountancy firm EIN	2022-11-30	410887288
2021 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$0
Total income from all sources (including contributions)	2021-12-31	$7,236,204
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$1,898,888
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$1,797,608
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$3,736,000
Value of total assets at end of year	2021-12-31	$27,680,234
Value of total assets at beginning of year	2021-12-31	$22,342,918
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$101,280
Total interest from all sources	2021-12-31	$5,984
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$1,889,406
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$1,889,406
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$2,298,857
Participant contributions at end of year	2021-12-31	$136,986
Participant contributions at beginning of year	2021-12-31	$129,281
Participant contributions at end of year	2021-12-31	$0
Participant contributions at beginning of year	2021-12-31	$61,133
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$502,571
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$5,337,316
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$27,680,234
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$22,342,918
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Investment advisory and management fees	2021-12-31	$65,515
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$25,976,385
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$20,393,160
Interest on participant loans	2021-12-31	$5,984
Value of interest in common/collective trusts at end of year	2021-12-31	$1,566,863
Value of interest in common/collective trusts at beginning of year	2021-12-31	$1,729,988
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$1,602,821
Net investment gain or loss from common/collective trusts	2021-12-31	$1,993
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	No
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$934,572
Employer contributions (assets) at end of year	2021-12-31	$0
Employer contributions (assets) at beginning of year	2021-12-31	$29,356
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$1,797,608
Contract administrator fees	2021-12-31	$35,765
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Disclaimer
Accountancy firm name	2021-12-31	BOULAY PLLP
Accountancy firm EIN	2021-12-31	410887288
2020 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$7,593,208
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$1,309,632
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$1,267,332
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$4,069,719
Value of total assets at end of year	2020-12-31	$22,342,918
Value of total assets at beginning of year	2020-12-31	$16,059,342
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$42,300
Total interest from all sources	2020-12-31	$4,929
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$545,898
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$545,898
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$2,194,316
Participant contributions at end of year	2020-12-31	$129,281
Participant contributions at beginning of year	2020-12-31	$103,627
Participant contributions at end of year	2020-12-31	$61,133
Participant contributions at beginning of year	2020-12-31	$60,612
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$778,866
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$6,283,576
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$22,342,918
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$16,059,342
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Investment advisory and management fees	2020-12-31	$8,750
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$20,393,160
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$14,481,859
Interest on participant loans	2020-12-31	$4,929
Value of interest in common/collective trusts at end of year	2020-12-31	$1,729,988
Value of interest in common/collective trusts at beginning of year	2020-12-31	$1,383,521
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$2,972,340
Net investment gain or loss from common/collective trusts	2020-12-31	$322
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$1,096,537
Employer contributions (assets) at end of year	2020-12-31	$29,356
Employer contributions (assets) at beginning of year	2020-12-31	$29,723
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$1,267,332
Contract administrator fees	2020-12-31	$33,550
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	BOULAY PLLP
Accountancy firm EIN	2020-12-31	410887288
2019 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$6,429,051
Total income from all sources (including contributions)	2019-12-31	$6,429,051
Total loss/gain on sale of assets	2019-12-31	$165,404
Total loss/gain on sale of assets	2019-12-31	$165,404
Total of all expenses incurred	2019-12-31	$816,105
Total of all expenses incurred	2019-12-31	$816,105
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$772,154
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$772,154
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$3,634,417
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$3,634,417
Value of total assets at end of year	2019-12-31	$16,059,342
Value of total assets at end of year	2019-12-31	$16,059,342
Value of total assets at beginning of year	2019-12-31	$10,446,396
Value of total assets at beginning of year	2019-12-31	$10,446,396
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$43,951
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$43,951
Total interest from all sources	2019-12-31	$7,761
Total interest from all sources	2019-12-31	$7,761
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$380,825
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$380,825
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$380,825
Administrative expenses professional fees incurred	2019-12-31	$43,951
Administrative expenses professional fees incurred	2019-12-31	$43,951
Was this plan covered by a fidelity bond	2019-12-31	Yes
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$1,000,000
Value of fidelity bond cover	2019-12-31	$1,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
If this is an individual account plan, was there a blackout period	2019-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$1,985,924
Contributions received from participants	2019-12-31	$1,985,924
Participant contributions at end of year	2019-12-31	$103,627
Participant contributions at end of year	2019-12-31	$103,627
Participant contributions at beginning of year	2019-12-31	$92,126
Participant contributions at beginning of year	2019-12-31	$92,126
Participant contributions at end of year	2019-12-31	$60,612
Participant contributions at end of year	2019-12-31	$60,612
Participant contributions at beginning of year	2019-12-31	$36,638
Participant contributions at beginning of year	2019-12-31	$36,638
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$423,774
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$423,774
Other income not declared elsewhere	2019-12-31	$52,050
Other income not declared elsewhere	2019-12-31	$52,050
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$5,612,946
Value of net income/loss	2019-12-31	$5,612,946
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$16,059,342
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$16,059,342
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$10,446,396
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$10,446,396
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$14,481,859
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$14,481,859
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,978,670
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$8,978,670
Interest on participant loans	2019-12-31	$7,761
Interest on participant loans	2019-12-31	$7,761
Value of interest in common/collective trusts at end of year	2019-12-31	$1,383,521
Value of interest in common/collective trusts at end of year	2019-12-31	$1,383,521
Value of interest in common/collective trusts at beginning of year	2019-12-31	$1,321,574
Value of interest in common/collective trusts at beginning of year	2019-12-31	$1,321,574
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$2,188,594
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$2,188,594
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$1,224,719
Contributions received in cash from employer	2019-12-31	$1,224,719
Employer contributions (assets) at end of year	2019-12-31	$29,723
Employer contributions (assets) at end of year	2019-12-31	$29,723
Employer contributions (assets) at beginning of year	2019-12-31	$17,388
Employer contributions (assets) at beginning of year	2019-12-31	$17,388
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$772,154
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$772,154
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$2,027,924
Aggregate proceeds on sale of assets	2019-12-31	$2,027,924
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$1,862,520
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$1,862,520
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BOULAY PLLP
Accountancy firm name	2019-12-31	BOULAY PLLP
Accountancy firm EIN	2019-12-31	410887288
Accountancy firm EIN	2019-12-31	410887288
2018 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2018 401k financial data
Total income from all sources (including contributions)	2018-12-31	$1,643,687
Total loss/gain on sale of assets	2018-12-31	$249,019
Total of all expenses incurred	2018-12-31	$1,348,452
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$1,332,804
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$2,236,976
Value of total assets at end of year	2018-12-31	$10,446,396
Value of total assets at beginning of year	2018-12-31	$10,151,161
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$15,648
Total interest from all sources	2018-12-31	$2,826
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$407,143
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$407,143
Administrative expenses professional fees incurred	2018-12-31	$15,648
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$750,000
If this is an individual account plan, was there a blackout period	2018-12-31	Yes
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$1,414,089
Participant contributions at end of year	2018-12-31	$92,126
Participant contributions at beginning of year	2018-12-31	$89,602
Participant contributions at end of year	2018-12-31	$36,638
Participant contributions at beginning of year	2018-12-31	$35,176
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$171,681
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$295,235
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$10,446,396
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$10,151,161
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$8,978,670
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$8,941,828
Interest on participant loans	2018-12-31	$2,826
Value of interest in common/collective trusts at end of year	2018-12-31	$1,321,574
Value of interest in common/collective trusts at beginning of year	2018-12-31	$1,037,738
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$29,768
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$29,768
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-1,252,277
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$651,206
Employer contributions (assets) at end of year	2018-12-31	$17,388
Employer contributions (assets) at beginning of year	2018-12-31	$17,049
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$1,332,804
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	Yes
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$1,617,800
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$1,368,781
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BOULAY PLLP
Accountancy firm EIN	2018-12-31	410887288
2017 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$2,998,917
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$705,391
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$692,310
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$1,746,742
Value of total assets at end of year	2017-12-31	$10,151,161
Value of total assets at beginning of year	2017-12-31	$7,857,635
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$13,081
Total interest from all sources	2017-12-31	$3,202
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$96,986
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$96,986
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$750,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$1,178,871
Participant contributions at end of year	2017-12-31	$89,602
Participant contributions at beginning of year	2017-12-31	$118,274
Participant contributions at end of year	2017-12-31	$35,176
Participant contributions at beginning of year	2017-12-31	$38,510
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$127,543
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$2,293,526
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$10,151,161
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$7,857,635
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$8,941,828
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$6,363,137
Interest on participant loans	2017-12-31	$3,202
Value of interest in common/collective trusts at end of year	2017-12-31	$1,037,738
Value of interest in common/collective trusts at beginning of year	2017-12-31	$1,208,464
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$29,768
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$1,127,407
Net investment gain or loss from common/collective trusts	2017-12-31	$24,580
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$440,328
Employer contributions (assets) at end of year	2017-12-31	$17,049
Employer contributions (assets) at beginning of year	2017-12-31	$129,250
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$692,310
Contract administrator fees	2017-12-31	$13,081
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	No
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BOULAY PLLP
Accountancy firm EIN	2017-12-31	410887288
2016 : ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$2,475,147
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$1,034,401
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$1,023,313
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$1,983,662
Value of total assets at end of year	2016-12-31	$7,857,635
Value of total assets at beginning of year	2016-12-31	$6,416,889
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$11,088
Total interest from all sources	2016-12-31	$2,897
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$91,828
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$91,828
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$1,043,312
Participant contributions at end of year	2016-12-31	$118,274
Participant contributions at beginning of year	2016-12-31	$71,789
Participant contributions at end of year	2016-12-31	$38,510
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$1,440,746
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$7,857,635
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$6,416,889
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$6,363,137
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$5,442,956
Interest on participant loans	2016-12-31	$2,897
Income. Interest from loans (other than to participants)	2016-12-31	$0
Value of interest in common/collective trusts at end of year	2016-12-31	$1,208,464
Value of interest in common/collective trusts at beginning of year	2016-12-31	$902,144
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$356,212
Net investment gain or loss from common/collective trusts	2016-12-31	$40,548
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$940,350
Employer contributions (assets) at end of year	2016-12-31	$129,250
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$1,023,313
Contract administrator fees	2016-12-31	$11,088
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	BOULAY PLLP
Accountancy firm EIN	2016-12-31	410887288

Form 5500 Responses for ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN

2022: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	Yes
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: ANTARES PHARMA, INC EMPLOYEE SAVINGS PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ANTARES PHARMA INC
Employer identification number (EIN):	411350192
NAIC Classification:	325410

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	3962625